NEWSDr. In-San Kim, a co-founder of SHIFTBIO INC., has been appointed as a fellow researcher at the Korea Institute of Science and Technology (KIST)

4 Nov 2022

The KIST fellow system is a new system established last year. This KIST fellow system supports to those eminent scholars for their continuous outstanding research activities, who have already made global-leading accomplishments.




The KIST explained Dr. Kim was selected as a Fellow member because “Dr. In-San Kim is an extraordinarily eminent integrative medicine scholar in Korea. Recently, he also proved himself as a global leader through the achievements of research on drug development based on natural nanoparticles, Ferrtine, and Extracellular Vesicles (EVs). Additionally, EV-based new drug platform technology, which is Dr. In-San Kim’s main field of study, is a branch with endless potential to be developed and utilized as a rare disease treatment research in our future.”

You can reach out to the full content by clicking the links below.

https://lnkd.in/gcSwdqnz

https://www.yna.co.kr/view/AKR20221101129700017?input=1195m

https://news.mt.co.kr/mtview.php?no=2022110117392528510

http://www.dt.co.kr/contents.html?article_no=2022110102109931731006&ref=naver

https://www.dongascience.com/news.php?idx=56916

https://biz.chosun.com/science-chosun/science/2022/11/01/IIIK4P7BYJDQPKIF4EMVBFC7LI/?utm_source=naver&utm_medium=original&utm_campaign=biz

https://www.newsworks.co.kr/news/articleView.html?idxno=613606

http://www.worktoday.co.kr/news/articleView.html?idxno=29819

http://news.heraldcorp.com/view.php?ud=20221101000575

http://www.ccnnews.co.kr/news/articleView.html?idxno=274456

https://www.hellodd.com/news/articleView.html?idxno=98522